Extended duration of treatment with peginterferon alfa‐2a in patients with chronic hepatitis B, HBeAg‐negative and E genotype: A retrospective analysis

L Boglione, G Cariti, V Ghisetti… - Journal of medical …, 2018 - Wiley Online Library
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)‐
interferon (IFN) is the prolonged course to 96 weeks of therapy, with higher sustained …
被引用次数：12 相关文章

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis.

L Boglione, G Cariti, V Ghisetti, E Burdino… - Journal of Medical …, 2018 - europepmc.org
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)-
interferon (IFN) is the prolonged course to 96 weeks of therapy, with higher sustained …

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis

L Boglione, G Cariti, V Ghisetti, E Burdino… - Journal of Medical …, 2018 - research.uniupo.it
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)-
interferon (IFN) is the prolonged course to 96 weeks of therapy, with higher sustained …

[引用][C] Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis

L Boglione, G Cariti, V Ghisetti, E Burdino… - JOURNAL OF MEDICAL …, 2018 - iris.unito.it
Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B,
HBeAg-negative and E genotype: A retrospective analysis IRIS IRIS Home Sfoglia …

Extended duration of treatment with peginterferon alfa‐2a in patients with chronic hepatitis B, HBeAg‐negative and E genotype: A retrospective analysis.

L Boglione, G Cariti, V Ghisetti… - Journal of Medical …, 2018 - search.ebscohost.com
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)‐
interferon (IFN) is the prolonged course to 96 weeks of therapy, with higher sustained …

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: a retrospective analysis.

L Boglione, G Cariti, V Ghisetti, E Burdino, G Perri - 2018 - cabidigitallibrary.org
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)-
interferon (IFN) is the prolonged course to 96 weeks of therapy, with higher sustained …

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis

L Boglione, G Cariti, V Ghisetti… - Journal of medical …, 2018 - pubmed.ncbi.nlm.nih.gov
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)-
interferon (IFN) is the prolonged course to 96 weeks of therapy, with higher sustained …

[引用][C] Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis

L Boglione, G Cariti, V Ghisetti, E Burdino… - JOURNAL OF …, 2018 - iris.uniupo.it
Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B,
HBeAg-negative and E genotype: A retrospective analysis IRIS IRIS Home Sfoglia …

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis

L Boglione, G Cariti, V Ghisetti, E Burdino… - Journal of Medical …, 2018 - research.uniupo.it
An alternative approach in the treatment of chronic hepatitis B (CHB) with pegylated (PEG)-
interferon (IFN) is the prolonged course to 96 weeks of therapy, with higher sustained …